Listed

Arbutus Biopharma Corp: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 13, 2015 and accepted by EDGAR at Mar 13, 2015, 16:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-10-01 to 2014-12-31$4.3mus-gaap:Revenues
Revenue12 months2014-01-01 to 2014-12-31$15.0mus-gaap:Revenues
Research and development12 months2014-01-01 to 2014-12-31$38.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-10-01 to 2014-12-31−$10.7mus-gaap:OperatingIncomeLoss
Operating income12 months2014-01-01 to 2014-12-31−$33.0mus-gaap:OperatingIncomeLoss
Net income3 months2014-10-01 to 2014-12-31−$6.2mus-gaap:NetIncomeLoss
Net income12 months2014-01-01 to 2014-12-31−$38.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-10-01 to 2014-12-31−$0.27us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2014-01-01 to 2014-12-31−$1.80us-gaap:EarningsPerShareDiluted
Basic EPS12 months2014-01-01 to 2014-12-31−$1.80us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2014-01-01 to 2014-12-3121,603,136 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2014-01-01 to 2014-12-31−$12.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2014-01-01 to 2014-12-31$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$72.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$116.4mus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$118.2mus-gaap:Assets
Current liabilitiesAt period end2014-12-31$20.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-12-31$30.1mus-gaap:Liabilities
Shareholders' equityAt period end2014-12-31$88.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001171843-15-001398. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.